Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Mar;45(5):581-592.
doi: 10.1111/apt.13905. Epub 2016 Dec 23.

Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm

J P Segal  1   2 , N S Ding  1   2 , G Worley  1   2 , S Mclaughlin  1 , S Preston  1 , O D Faiz  2 , S K Clark  2 , A L Hart  1   2
Affiliations
Free article
Meta-Analysis

Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm

J P Segal et al. Aliment Pharmacol Ther. 2017 Mar.
Free article

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] Aliment Pharmacol Ther. 2018 Mar;47(6):864. doi: 10.1111/apt.14534. Aliment Pharmacol Ther. 2018. PMID: 29446140 No abstract available.

Abstract

Background: Restorative proctocolectomy with ileal pouch anal anastomosis (IPAA) is considered the procedure of choice in patients with ulcerative colitis (UC) refractory to medical therapy. The incidence of pouchitis is 40% at 5 years. Ten to 15% of patients with pouchitis experience chronic pouchitis.

Aim: To determine the efficacy of medical therapies for the treatment of chronic refractory pouchitis in patients undergoing IPAA for UC.

Methods: A systematic computer-assisted search of the on-line bibliographic database MEDLINE and EMBASE was performed between 1966 and February 2016. All original studies reporting remission rates following medical treatment for chronic pouchitis were included. All study designs were considered. Remission was defined according to the individual study. Remission endpoints ranged from 15 days to 10 weeks. Chronic pouchitis was defined by each study.

Results: Twenty-one papers were considered eligible. Results from all studies combined suggested that overall remission was obtained in 59% of patients (95% CI: 44-73%). Antibiotics significantly induced remission in patients with chronic pouchitis with 74% remission rate (95% CI:56-93%), (P < 0.001). Biologics significantly induced remission in patients with chronic pouchitis with 53% remission rate (95% CI:30-76%), (P < 0.001). Steroids, bismuth, elemental diet and tacrolimus all can induce remission but failed to achieve significance. Faecal microbiota transplantation in a single study was not found to achieve remission.

Conclusions: Treatment of chronic refractory pouchitis remains difficult and is largely empirical. Larger randomised controlled trials will help aid the management of chronic pouchitis.

PubMed Disclaimer